Literature DB >> 19725469

Rapid detection of rpoB gene mutations in rif-resistant M. tuberculosis isolates by oligonucleotide microarray.

Ai-Hua Sun1, Xing-Li Fan, Li-Wei Li, Li-Fang Wang, Wen-Ying Ans, Jie Yan.   

Abstract

OBJECTIVE: To detect the specific mutations in rpoB gene of Mycobacterium tuberculosis by oligonucleotide microarray.
METHODS: Four wild-type and 8 mutant probes were used to detect rifampin resistant strains. Target DNA of M. tuberculosis was amplified by PCR, hybridized and scanned. Direct sequencing was performed to verify the results of oligonucleotide microarray.
RESULTS: Of the 102 rifampin-resistant strains 98 (96.1%) had mutations in the rpoB genes.
CONCLUSION: Oligonucleotide microarray with mutation-specific probes is a reliable and useful tool for the rapid and accurate diagnosis of rifampin resistance in M. tuberculosis isolates.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19725469     DOI: 10.1016/s0895-3988(09)60053-2

Source DB:  PubMed          Journal:  Biomed Environ Sci        ISSN: 0895-3988            Impact factor:   3.118


  3 in total

1.  Demonstrating a multi-drug resistant Mycobacterium tuberculosis amplification microarray.

Authors:  Yvonne Linger; Alexander Kukhtin; Julia Golova; Alexander Perov; Peter Qu; Christopher Knickerbocker; Christopher G Cooney; Darrell P Chandler
Journal:  J Vis Exp       Date:  2014-04-25       Impact factor: 1.355

2.  Genotyping Multidrug-Resistant Mycobacterium tuberculosis from Primary Sputum and Decontaminated Sediment with an Integrated Microfluidic Amplification Microarray Test.

Authors:  Yvonne Linger; Christopher Knickerbocker; David Sipes; Julia Golova; Molly Franke; Roger Calderon; Leonid Lecca; Nitu Thakore; Rebecca Holmberg; Peter Qu; Alexander Kukhtin; Megan B Murray; Christopher G Cooney; Darrell P Chandler
Journal:  J Clin Microbiol       Date:  2018-02-22       Impact factor: 5.948

3.  Rapid and accurate detection of RMP- and INH- resistant Mycobacterium tuberculosis in spinal tuberculosis specimens by CapitalBio™ DNA microarray: a prospective validation study.

Authors:  Zehua Zhang; Litao Li; Fei Luo; Peng Cheng; Feng Wu; Zheng Wu; Tianyong Hou; Min Zhong; Jianzhong Xu
Journal:  BMC Infect Dis       Date:  2012-11-14       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.